Spandidos Publications style
Romero RZ, Morales R, Garcia F, Huarriz M, Bandres E, De la Haba J, Gómez A, Aranda E and García-Foncillas J: Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients. Oncol Rep 16: 497-503, 2006.
APA
Romero, R.Z., Morales, R., Garcia, F., Huarriz, M., Bandres, E., De la Haba, J. ... García-Foncillas, J. (2006). Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients. Oncology Reports, 16, 497-503. https://doi.org/10.3892/or.16.3.497
MLA
Romero, R. Z., Morales, R., Garcia, F., Huarriz, M., Bandres, E., De la Haba, J., Gómez, A., Aranda, E., García-Foncillas, J."Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients". Oncology Reports 16.3 (2006): 497-503.
Chicago
Romero, R. Z., Morales, R., Garcia, F., Huarriz, M., Bandres, E., De la Haba, J., Gómez, A., Aranda, E., García-Foncillas, J."Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients". Oncology Reports 16, no. 3 (2006): 497-503. https://doi.org/10.3892/or.16.3.497
